{"id":"https://openalex.org/W2092398087","doi":"https://doi.org/10.1016/j.amjcard.2014.03.045","title":"Efficacy, Safety, Tolerability, and Pharmacokinetic Profile of Evacetrapib Administered as Monotherapy or in Combination With Atorvastatin in Japanese Patients With Dyslipidemia","display_name":"Efficacy, Safety, Tolerability, and Pharmacokinetic Profile of Evacetrapib Administered as Monotherapy or in Combination With Atorvastatin in Japanese Patients With Dyslipidemia","publication_year":2014,"publication_date":"2014-04-02","ids":{"openalex":"https://openalex.org/W2092398087","doi":"https://doi.org/10.1016/j.amjcard.2014.03.045","mag":"2092398087","pmid":"https://pubmed.ncbi.nlm.nih.gov/24786356"},"language":"en","primary_location":{"id":"doi:10.1016/j.amjcard.2014.03.045","doi":"https://doi.org/10.1016/j.amjcard.2014.03.045","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.amjcard.2014.03.045","pdf_url":"http://www.ajconline.org/article/S0002914914008881/pdf","source":{"id":"https://openalex.org/S185186944","display_name":"The American Journal of Cardiology","issn_l":"0002-9149","issn":["0002-9149","1879-1913"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal of Cardiology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.ajconline.org/article/S0002914914008881/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102165046","display_name":"Tamio Teramoto","orcid":"https://orcid.org/0000-0002-8121-7484","observed_orcids":["https://orcid.org/0000-0002-8121-7484"]},"institutions":[{"id":"https://openalex.org/I87531838","display_name":"Teikyo University","ror":"https://ror.org/01gaw2478","country_code":"JP","type":"education","lineage":["https://openalex.org/I87531838"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tamio Teramoto","raw_affiliation_strings":["Teikyo Academic Research Center, Teikyo University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teikyo Academic Research Center, Teikyo University, Tokyo, Japan","institution_ids":["https://openalex.org/I87531838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018046892","display_name":"Masakazu Takeuchi","orcid":"https://orcid.org/0000-0003-3176-3118","observed_orcids":["https://orcid.org/0000-0003-3176-3118"]},"institutions":[{"id":"https://openalex.org/I4210108315","display_name":"Eli Lilly (Japan)","ror":"https://ror.org/01sv7f575","country_code":"JP","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210108315"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Masakazu Takeuchi","raw_affiliation_strings":["Eli Lilly Japan K.K., Kobe, Japan. Electronic address: takeuchi_masakazu@yahoo.co.jp","Eli Lilly Japan K.K. Kobe Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly Japan K.K., Kobe, Japan. Electronic address: takeuchi_masakazu@yahoo.co.jp","institution_ids":["https://openalex.org/I4210108315"]},{"raw_affiliation_string":"Eli Lilly Japan K.K. Kobe Japan","institution_ids":["https://openalex.org/I4210108315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111197473","display_name":"Yoji Morisaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108315","display_name":"Eli Lilly (Japan)","ror":"https://ror.org/01sv7f575","country_code":"JP","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210108315"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoji Morisaki","raw_affiliation_strings":["Eli Lilly Japan K.K., Kobe, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly Japan K.K., Kobe, Japan","institution_ids":["https://openalex.org/I4210108315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078824497","display_name":"Giacomo Ruotolo","orcid":"https://orcid.org/0000-0001-5247-5444","observed_orcids":["https://orcid.org/0000-0001-5247-5444"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giacomo Ruotolo","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110181039","display_name":"Kathryn A. Krueger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathryn A. Krueger","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5018046892"],"corresponding_institution_ids":["https://openalex.org/I4210108315"],"apc_list":{"value":3380,"currency":"USD","value_usd":3380},"apc_paid":{"value":3380,"currency":"USD","value_usd":3380},"fwci":6.2761,"has_fulltext":true,"cited_by_count":29,"citation_normalized_percentile":{"value":0.96836258,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"113","issue":"12","first_page":"2021","last_page":"2029"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/evacetrapib","display_name":"evacetrapib","score":0.996999979019165},{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.8690000176429749},{"id":"https://openalex.org/keywords/cholesteryl-ester-transfer-protein-inhibitors","display_name":"cholesteryl ester transfer protein inhibitors","score":0.8690000176429749},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9359999895095825},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.6389999985694885},{"id":"https://openalex.org/keywords/hdl-cholesterol-elevation","display_name":"HDL cholesterol elevation","score":0.9340000152587891},{"id":"https://openalex.org/keywords/cetp-activity","display_name":"CETP activity","score":0.7879999876022339},{"id":"https://openalex.org/keywords/statin-combination-therapy","display_name":"statin combination therapy","score":0.8450000286102295},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8889999985694885},{"id":"https://openalex.org/keywords/washout","display_name":"washout","score":0.5709999799728394},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.8090000152587891},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.7070000171661377},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.8180000185966492},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.5759999752044678},{"id":"https://openalex.org/keywords/lipid-lowering","display_name":"lipid lowering","score":0.49900001287460327}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9338365793228149},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.8999291658401489},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8868653774261475},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.8736470937728882},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6359970569610596},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.528005838394165},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5224596261978149},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5089926719665527},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3894007205963135},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2665841579437256},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.10684862732887268}],"mesh":[{"descriptor_ui":"D000069059","descriptor_name":"Atorvastatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006538","descriptor_name":"Heptanoic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006538","descriptor_name":"Heptanoic Acids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D053480","descriptor_name":"Cholesterol Ester Transfer Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.amjcard.2014.03.045","doi":"https://doi.org/10.1016/j.amjcard.2014.03.045","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.amjcard.2014.03.045","pdf_url":"http://www.ajconline.org/article/S0002914914008881/pdf","source":{"id":"https://openalex.org/S185186944","display_name":"The American Journal of Cardiology","issn_l":"0002-9149","issn":["0002-9149","1879-1913"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal of Cardiology","raw_type":"journal-article"},{"id":"pmid:24786356","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24786356","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of cardiology","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:irdb.nii.ac.jp:00953:0006791802","doi":null,"is_oa":false,"landing_page_url":"https://pure.teikyo.jp/en/publications/d840509b-d3d5-4e89-89ff-37658f2dc2c9","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Journal of Cardiology","raw_type":"journal article"}],"best_oa_location":{"id":"doi:10.1016/j.amjcard.2014.03.045","doi":"https://doi.org/10.1016/j.amjcard.2014.03.045","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.amjcard.2014.03.045","pdf_url":"http://www.ajconline.org/article/S0002914914008881/pdf","source":{"id":"https://openalex.org/S185186944","display_name":"The American Journal of Cardiology","issn_l":"0002-9149","issn":["0002-9149","1879-1913"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal of Cardiology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6100000143051147}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2092398087.pdf","grobid_xml":"https://content.openalex.org/works/W2092398087.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1973355122","https://openalex.org/W1983315526","https://openalex.org/W1999461242","https://openalex.org/W2011755568","https://openalex.org/W2030697498","https://openalex.org/W2046343341","https://openalex.org/W2048481833","https://openalex.org/W2048760408","https://openalex.org/W2049920552","https://openalex.org/W2068244957","https://openalex.org/W2082643036","https://openalex.org/W2089084813","https://openalex.org/W2090464684","https://openalex.org/W2110549854","https://openalex.org/W2118825330","https://openalex.org/W2152683287","https://openalex.org/W2159243445","https://openalex.org/W2164934684"],"related_works":["https://openalex.org/W2159243445","https://openalex.org/W2739516387","https://openalex.org/W2330251140","https://openalex.org/W2710438441","https://openalex.org/W2046343341","https://openalex.org/W2220294725","https://openalex.org/W2790060225","https://openalex.org/W2137621821","https://openalex.org/W2193506619","https://openalex.org/W2087603107"],"abstract_inverted_index":{"The":[0],"cholesteryl":[1],"ester":[2],"transfer":[3],"protein":[4],"(CETP)":[5],"inhibitor":[6],"evacetrapib":[7,51,64,76,120,167,207,236],"has":[8],"been":[9],"previously":[10],"shown":[11],"to":[12,48,145,156,183,226,231],"increase":[13],"high-density":[14],"lipoprotein":[15,21],"cholesterol":[16,22],"(HDL-C)":[17],"and":[18,84,86,93,95,101,107,128,134,150,153,163,193,212,217,220,223,248,251],"decrease":[19],"low-density":[20],"(LDL-C)":[23],"levels,":[24],"as":[25,237],"monotherapy":[26,52,77,174,238],"or":[27,41,57,63,175,202,239],"in":[28,67,159,176,190,240,258],"combination":[29,68,115,177,241],"with":[30,38,69,116,178,186,242,261],"statins.":[31],"In":[32,114,234],"this":[33],"study,":[34],"165":[35],"Japanese":[36,259],"patients":[37,165,260],"elevated":[39],"LDL-C":[40,88,130,218,249],"low":[42],"HDL-C":[43,79,124,253],"levels":[44,80,89,125,131,158,219,250,254],"were":[45,209],"randomly":[46],"assigned":[47],"receive":[49],"placebo,":[50],"30":[53],"mg,":[54,56,59,62,119],"100":[55,65,121],"500":[58],"atorvastatin":[60,70,117,140,179,243],"10":[61,71,118],"mg":[66,122],"mg.":[72],"After":[73,142],"12":[74,256],"weeks,":[75],"increased":[78,123,252],"by":[81,90,98,126,132,137],"74%,":[82],"115%,":[83],"136%":[85],"decreased":[87,129,245],"15%,":[91],"23%,":[92],"22%":[94],"CETP":[96,135,151,221,246],"activity":[97,136,154,247],"50%,":[99],"83%,":[100],"95%":[102],"(for":[103],"the":[104,160,170],"30-mg,":[105],"100-mg,":[106],"500-mg":[108],"dose":[109],"groups,":[110,162],"respectively)":[111],"versus":[112,139],"placebo.":[113],"103%":[127],"15%":[133],"68%":[138],"alone.":[141],"a":[143,229],"4-":[144,230],"6-week":[146,232],"washout,":[147],"HDL-C,":[148],"LDL-C,":[149],"mass":[152,222],"returned":[155,225],"baseline":[157,227],"evacetrapib-treated":[161],"most":[164],"had":[166],"concentrations":[168,208],"below":[169],"quantitation":[171],"limit.":[172],"Evacetrapib":[173],"was":[180],"not":[181,195],"likely":[182],"be":[184],"associated":[185],"any":[187,197],"significant":[188],"change":[189],"blood":[191],"pressure":[192],"did":[194],"have":[196],"adverse":[198],"effects":[199],"on":[200],"mineralocorticoid":[201],"glucocorticoid":[203],"measures.":[204],"Notably,":[205],"plasma":[206],"mostly":[210],"undetectable,":[211],"all":[213],"pharmacodynamic":[214],"biomarkers":[215],"(HDL-C":[216],"activity)":[224],"after":[228,255],"washout.":[233],"conclusion,":[235],"effectively":[244],"weeks":[257],"dyslipidemia.":[262]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}